title: Evaluation of affinity microcolumns containing human serum albumin for rapid analysis of drug-protein binding.
abstract: This study examined the use of affinity microcolumns as tools for the rapid analysis and high-throughput screening of drug-protein binding. The protein used was immobilized human serum albumin (HSA) and the model analytes were warfarin and L-tryptophan, two solutes often used as site-specific probes for drug binding to Sudlow sites I and II of HSA, respectively. The use of HSA microcolumns in binding studies was examined by using both zonal elution and frontal analysis formats. The zonal elution studies were conducted by injecting the probe compounds onto HSA microcolumns of varying lengths while measuring the resulting retention factors, plate heights and peak asymmetries. A decrease in the retention factor was noted when moving from longer to shorter column lengths while using a constant amount of injected solute. However, this change could be corrected, in part, by determining the relative retention factor of a solute versus a reference compound injected onto the same microcolumn. The plate height values were relatively consistent for all column lengths and gave an expected increase at higher linear velocities. The peak asymmetries were similar for all columns up to 1 mL/min but shifted to larger values at higher flow rates and when using short microcolumns (e.g., 1 mm length). The association equilibrium constants and number of binding sites estimated by frontal analysis for warfarin with HSA were consistent at the various column sizes that were tested and gave good agreement with previous literature values. These results confirmed affinity microcolumns provide comparable results to those obtained with longer columns and can be used in the rapid analysis of drug-protein binding and in the high-throughput screening of such interactions.
authors.affiliation: Department of Chemistry, University of Nebraska-Lincoln, 704 Hamilton Hall, Lincoln, NE 68588-0304, USA.
authors.forename: Michelle J
authors.initials: MJ
authors.lastname: Yoo
authors.forename: John E
authors.initials: JE
authors.lastname: Schiel
authors.forename: David S
authors.initials: DS
authors.lastname: Hage
mesh_terms: D002846:Chromatography, Affinity / Q000379:methods*; D006801:Humans; D007700:Kinetics; D004364:Pharmaceutical Preparations / Q000737:chemistry; D011485:Protein Binding; D012709:Serum Albumin / Q000737:chemistry*; D014364:Tryptophan / Q000737:chemistry*; D014859:Warfarin / Q000737:chemistry*
chemical_list: D004364:Pharmaceutical Preparations; D012709:Serum Albumin; D014859:Warfarin; D014364:Tryptophan
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2006 May 19;836(1-2):83-91
references.pmid: 16621742
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Sep 25;809(1):137-45
references.pmid: 15282104
references.citation: Drug Metab Pharmacokinet. 2005 Oct;20(5):309-23
references.pmid: 16272748
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jun 6;837(1-2):138-46
references.pmid: 16687257
references.citation: J Chromatogr B Biomed Sci Appl. 2000 Feb 28;739(1):39-54
references.pmid: 10744312
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jul 1;870(1):22-6
references.pmid: 18554995
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Feb 25;768(1):3-30
references.pmid: 11939555
references.citation: Anal Chem. 1994 Nov 1;66(21):3814-22
references.pmid: 7802261
references.citation: Anal Biochem. 1985 Oct;150(1):76-85
references.pmid: 3843705
references.citation: Methods Enzymol. 1984;104:212-23
references.pmid: 6371445
references.citation: Anal Biochem. 2003 Aug 1;319(1):1-12
references.pmid: 12842101
references.citation: J Sep Sci. 2009 Aug;32(15-16):2776-85
references.pmid: 19630007
references.citation: J Sep Sci. 2009 Apr;32(8):1145-55
references.pmid: 19296478
references.citation: J Chromatogr. 1979 Nov 28;180(1):103-10
references.pmid: 541445
references.citation: J Chromatogr A. 1994 May 27;669(1-2):9-19
references.pmid: 8055106
references.citation: Comb Chem High Throughput Screen. 2002 Aug;5(5):395-406
references.pmid: 12180905
references.citation: J Chromatogr A. 1997 Apr 4;766(1-2):15-25
references.pmid: 9134727
references.citation: J Sep Sci. 2009 Mar;32(5-6):835-53
references.pmid: 19278006
references.citation: Anal Chem. 2004 Dec 1;76(23):440A-448A
references.pmid: 15595185
references.citation: J Chromatogr A. 2009 Apr 17;1216(16):3492-500
references.pmid: 18926542
references.citation: Pharmacol Rev. 1981 Mar;33(1):17-53
references.pmid: 7027277
references.citation: Mol Pharmacol. 1976 Nov;12(6):1052-61
references.pmid: 1004490
references.citation: J Chromatogr. 1993 Aug 20;645(2):241-50
references.pmid: 8408417
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Dec 1;876(1):69-75
references.pmid: 18980867
references.citation: Anal Chem. 2006 Apr 15;78(8):2672-83
references.pmid: 16615779
references.citation: Curr Med Chem. 2002 Aug;9(15):1463-81
references.pmid: 12173977
references.citation: J Pharm Biomed Anal. 2006 Jun 16;41(4):1101-9
references.pmid: 16545534
references.citation: J Chromatogr A. 2009 May 1;1216(18):3794-801
references.pmid: 19272606
references.citation: J Chromatogr. 1992 Jun 10;577(2):305-15
references.pmid: 1400761
references.citation: J Chromatogr. 1992 Sep 2;579(2):225-35
references.pmid: 1429970